Tianjin Ringpu Bio-Technology Co.,Ltd.
Shenzhen Stock ExchangeTotal Valuation
Tianjin Ringpu Bio-Technology Co.,Ltd. carries a market capitalization of 7.43B, placing it among publicly traded companies globally. Its enterprise value stands at 9.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.43B |
| Enterprise Value | 9.13B |
Share Statistics
Tianjin Ringpu Bio-Technology Co.,Ltd. currently has 464.75M shares outstanding.
| Shares Outstanding | 464.75M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Tianjin Ringpu Bio-Technology Co.,Ltd. trades at a trailing price-to-earnings ratio of 22.20. The price-to-sales ratio is 2.40, and the price-to-book ratio stands at 3.72.
| PE Ratio | 22.20 |
| PS Ratio | 2.40 |
| PB Ratio | 3.72 |
| P/TBV Ratio | 2.23 |
| P/FCF Ratio | 56.20 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Tianjin Ringpu Bio-Technology Co.,Ltd. trades at an EV/EBITDA multiple of 17.53 and an EV/FCF ratio of 48.23. The EV/Sales ratio of 2.48 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.53 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.48 |
| EV / EBITDA | 17.53 |
| EV / EBIT | 17.53 |
| EV / FCF | 48.23 |
Financial Position
Tianjin Ringpu Bio-Technology Co.,Ltd. maintains a current ratio of 1.85, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 31.86, indicating elevated leverage, while an interest coverage ratio of 14.37 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.85 |
| Quick Ratio | 0.93 |
| Debt / Equity | 31.86 |
| Debt / EBITDA | 3.11 |
| Interest Coverage | 14.37 |
Financial Efficiency
Tianjin Ringpu Bio-Technology Co.,Ltd. posts a return on equity of 17.75 and a return on invested capital of 7.30.
| Return on Equity (ROE) | 17.75 |
| Return on Assets (ROA) | 5.26 |
| Return on Invested Capital (ROIC) | 7.30 |
| Return on Capital Employed (ROCE) | 9.60 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.80 |
Taxes
Over the trailing twelve months, Tianjin Ringpu Bio-Technology Co.,Ltd. has paid 57.40M in income taxes, reflecting an effective tax rate of 11.68.
| Income Tax | 57.40M |
| Effective Tax Rate | 11.68 |
Stock Price Statistics
Tianjin Ringpu Bio-Technology Co.,Ltd.'s stock has declined approximately -19.4864% over the past 52 weeks. The 50-day moving average sits at 16.42, while the 200-day moving average is 18.89.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.4864% |
| 50-Day Moving Average | 16.42 |
| 200-Day Moving Average | 18.89 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Tianjin Ringpu Bio-Technology Co.,Ltd. generated 3.68B in revenue and converted that into 398.11M in net income, yielding earnings per share of 0.95. EBITDA reached 520.84M, while operating income came in at 520.84M.
| Revenue | 3.68B |
| Gross Profit | 1.46B |
| Operating Income | 520.84M |
| Pretax Income | 491.49M |
| Net Income | 398.11M |
| EBITDA | 520.84M |
| EBIT | 520.84M |
| Earnings Per Share (EPS) | 0.95 |
Balance Sheet
Tianjin Ringpu Bio-Technology Co.,Ltd. holds 1.86B in cash and equivalents against 1.62B in total debt, resulting in a net debt position of 1.02B. Total book value stands at 2.37B, with working capital of 1.70B providing operational flexibility.
| Cash & Cash Equivalents | 1.86B |
| Total Debt | 1.62B |
| Net Debt | 1.02B |
| Equity (Book Value) | 2.37B |
| Book Value Per Share | 5.21 |
| Working Capital | 1.70B |
Cash Flow
After subtracting -157.25M in capital expenditures, free cash flow totaled -157.25M - equivalent to -0.35 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -157.25M |
| Free Cash Flow | -157.25M |
| FCF Per Share | -0.35 |
Margins
Tianjin Ringpu Bio-Technology Co.,Ltd. operates with a gross margin of 39.56, reflecting its pricing power and cost economics. The operating margin of 14.16 and net profit margin of 10.82 provide insight into operational efficiency.
| Gross Margin | 39.56 |
| Operating Margin | 14.16 |
| Pretax Margin | 13.36 |
| Profit Margin | 10.82 |
| EBITDA Margin | 14.16 |
Dividends & Yields
The company's payout ratio of 35.40 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.37 |
| Dividend Yield | N/A |
| Payout Ratio | 35.40 |
| Shareholder Yield | 0.02 |
| FCF Yield | 1.78 |
Stock Splits
Tianjin Ringpu Bio-Technology Co.,Ltd.'s most recent stock split took place on April 22, 2014 with a 1000000:1993579 split ratio.
| Last Split Date | 4/22/2014 |
| Split Ratio | 1000000:1993579 |
Scores
Tianjin Ringpu Bio-Technology Co.,Ltd. posts an Altman Z-Score of 3.33, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.33 |